|Plasma ghrelin following cure of Helicobacter pylori|
CU Nwokolo, DA Freshwater, P O’hare, HS Randeva
Gut 52 (5), 637-640, 2003
|Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.|
JT Smith, RE Pounder, CU Nwokolo, S Lanzon-Miller, DG Evans, ...
Gut 31 (5), 522-525, 1990
|Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus|
Z Su, LJ Gay, A Strange, C Palles, G Band, DC Whiteman, F Lescai, ...
Nature genetics 44 (10), 1131-1136, 2012
|Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study|
NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ...
The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019
|Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.|
CU Nwokolo, JT Smith, C Gavey, A Sawyerr, RE Pounder
Alimentary pharmacology & therapeutics 4, 29-45, 1990
|Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis|
RP Arasaradnam, MJ McFarlane, C Ryan-Fisher, E Westenbrink, ...
PloS one 9 (9), e108750, 2014
|Development and application of a new electronic nose instrument for the detection of colorectal cancer|
E Westenbrink, RP Arasaradnam, N O'Connell, C Bailey, C Nwokolo, ...
Biosensors and Bioelectronics 67, 733-738, 2015
|Next generation diagnostic modalities in gastroenterology–gas phase volatile compound biomarker detection|
RP Arasaradnam, JA Covington, C Harmston, CU Nwokolo
Alimentary pharmacology & therapeutics 39 (8), 780-789, 2014
|Eradication of Helicobacter pylori abolishes 24‐hour hypergastrinaemia: a prospective study in healthy subjects|
EJ Prewett, JTL Smith, CU Nwokolo, M Hudson, AM Sawyerr, RE Pounder
Alimentary pharmacology & therapeutics 5 (3), 283-290, 1991
|Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus|
C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ...
Gastroenterology 148 (2), 367-378, 2015
|Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.|
CU Nwokolo, JT Smith, AM Sawyerr, RE Pounder
Gut 32 (12), 1455-1460, 1991
|Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?|
A Dhaliwal, Z Zeino, C Tomkins, M Cheung, C Nwokolo, S Smith, ...
Frontline Gastroenterology 6 (1), 14-19, 2015
|Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non‐alcoholic steatohepatitis|
A Sajjad, M Mottershead, WK Syn, R Jones, S Smith, CU Nwokolo
Alimentary pharmacology & therapeutics 22 (4), 291-299, 2005
|Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.|
JT Smith, C Gavey, CU Nwokolo, RE Pounder
Alimentary pharmacology & therapeutics 4, 47-63, 1990
|Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial|
C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ...
The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016
|Surgical resections in parous patients with distal ileal and colonic Crohn's disease.|
CU Nwokolo, WC Tan, HA Andrews, RN Allan
Gut 35 (2), 220-223, 1994
|Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate|
CJ Gavey, ML Szeto, CU Nwokolo, J Sercombe, RE Pounder
Alimentary pharmacology & therapeutics 3 (1), 21-28, 1989
|A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease|
RP Arasaradnam, N Ouaret, MG Thomas, N Quraishi, E Heatherington, ...
Inflammatory bowel diseases 19 (5), 999-1003, 2013
|The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate|
CU Nwokolo, CJ Gavey, JTL Smith, RE Pounder
Alimentary pharmacology & therapeutics 3 (1), 29-39, 1989
|Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients|
MM Widlak, CL Thomas, MG Thomas, C Tomkins, S Smith, N O'Connell, ...
Alimentary pharmacology & therapeutics 45 (2), 354-363, 2017